4
Changes in Ownership
Natera, Inc. Filed Acc 0001415889-24-030182
PRESIDENT, CLINICALDIAGNOSTICS sold 2,428 shares at an average $159.60 ($387,511)
- PRESIDENT, CLINICALDIAGNOSTICS acquired 4,719 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-20 | Grant or award : show line 1 in the form 10b5-1 | +1,675 | 116,381 | D | ||
| 2024-12-20 | Grant or award : show line 2 in the form 10b5-1 | +3,044 | 119,425 | D | ||
| 2024-12-23 | Sale : show line 3 in the form 10b5-1 | −2 | $158.06 | $316 | 119,423 | D |
| 2024-12-23 | Sale : show line 4 in the form 10b5-1 | −3 | $158.19 | $475 | 119,420 | D |
| 2024-12-23 | Sale : show line 5 in the form 10b5-1 | −2,423 | $159.60 | $386,721 | 116,997 | D |
| Open-market sales · 2,428 sh · avg $159.60 · $387,511 | ||||||
Loading xslF345X05/form4-12262024_091201.xml…